None of these forms have FDA approval for treating mold toxicity, and clinical outcome data in mold-exposed populations is limited
For each study included in the review, we extracted detailed information on the study design, sample size, participant characteristics, type and dosage of GLP-1 RA used, and the key outcomes measured
Long-term success depends on consistent medication use and maintaining healthy lifestyle habits
Pachyonychia congenita: therapeutic and immunologic aspects
A provider-guided semaglutide program may help eligible patients: reduce appetite improve fullness after meals support steady weight loss over time improve adherence to a nutrition plan build better long-term habits with medical oversight The best results typically happen when medication is paired with nutrition guidance, activity, follow-up care, and realistic lifestyle changes